Phenotyping Left Ventricular Obstruction With Postprandial Re-Test Echocardiography in Hypertrophic Cardiomyopathy

Giovanni La Canna1, Iside Scarfò1, Iryna Arendar1

  • 1Applied Diagnostic Echocardiography Unit, Cardiovascular Department, Humanitas Clinical and Research Hospital, Rozzano-Milan, Italy.

Insights

Postprandial echocardiography effectively reveals dynamic left ventricular obstruction in hypertrophic cardiomyopathy patients, surpassing traditional fasting tests. This simple method aids in diagnosing obstructive phenotypes and refining treatment strategies.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Hypertrophic Cardiomyopathy Research

Background:

  • Dynamic left ventricular (LV) obstruction is clinically significant in hypertrophic cardiomyopathy (HC).
  • Obstruction may manifest under stress, potentially linked to postprandial (PP) symptoms.
  • Current diagnostic methods may not fully capture latent obstruction.

Purpose of the Study:

  • To assess the inducibility of PP-LV obstruction in HC patients.
  • To compare PP-LV obstruction detection with fasting Valsalva maneuver and exercise tests.
  • To identify factors associated with PP-LV obstruction.

Main Methods:

  • Ninety-two HC patients without baseline obstruction underwent at-rest Transthoracic Echocardiography (TTE).
  • Tests included fasting Valsalva, exercise, and a PP-TTE 30-60 minutes post-meal.
  • LV obstruction was classified (SAM-related, non-SAM-related), and intraventricular gradients measured.

Main Results:

  • PP-TTE identified significant intraventricular gradients in 74% of patients, reclassifying them as obstructive.
  • This prevalence was significantly higher than with fasting Valsalva (23%) or exercise (33%) (p < 0.001).
  • PP symptoms, mitral anterior leaflet length, and LV outflow ratio >2 correlated with PP-TTE obstruction.

Conclusions:

  • Postprandial TTE re-test is a simple, effective tool for unmasking latent LV dynamic obstruction in HC.
  • It surpasses fasting Valsalva and exercise tests in detecting obstructive phenotypes.
  • Refining the PP clinical phenotype is crucial for HC management and therapy evaluation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
283
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
298
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
154